ISABELLE MAGANA: Open Payments
NPI 1417631771 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 39 payments from 12 companies in 2025. Trend: 2023 $123 · 2024 $2,875 · 2025 $969
Food & beverage: $948Education: $20
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 10 | $316 |
| E.R. Squibb & Sons, L.L.C. | 6 | $165 |
| Actelion Pharmaceuticals US, Inc. | 5 | $118 |
| Abbott Laboratories | 4 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| SCPHARMACEUTICALS INC. | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Edwards Lifesciences Corporation | 2 | $39 |
| Medtronic, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
Products named: VERQUVO, ELIQUIS, WINREVAIR, CARDIOMEMS, OPSUMIT, FUROSCIX, LEQVIO, Kerendia.
Industry payments across CA — which companies pay providers there.
